Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Website: cormedix.com

Address:

389 Interpace Pkwy, Suite 450, Parsippany, United States

ReturnOfEsquire May. 15 at 2:54 PM

$CRMD I'm no legislative expert, but 20 co-sponsors sounds like a lot to me. That's almost 5% of House of Representatives. And it's bipartisan. Hard to believe this would get derailed.

0 · Reply

CRMDepressed May. 15 at 2:52 PM

$CRMD ……wtf man

0 · Reply

golfguy42360 May. 15 at 2:50 PM

$CRMD Dumped another 500 shares today while I'm up .Been loading up on $FNUC been on a tear last couple days.sick of of this incompetent CEO.

0 · Reply

Shibby_Boss May. 15 at 2:42 PM

$CRMD did pur CEO start speaking?

0 · Reply

richmando May. 15 at 2:31 PM

$CRMD who would have thought we were a chip stock.

0 · Reply

richmando May. 15 at 2:27 PM

$CRMD Do we FLIP or what

0 · Reply

richmando May. 15 at 2:23 PM

$CRMD is he using up his OTB this morning if not WTF shorts are driving the price down by what hitting stops ( I doubt that).....So what?? opinions are welcome since we're trading at the most ridiculous #'s all the p/b pe. trailing and better than expected news regardless of sandbagging. reading between lines about the 2 month qtr. A count and fill business with a 4 week on hand depending on delivery time needed which we have heard of no ISSUE'S. ergo they ordered 3x's but at EOM, not the beginning. So Joe Front LOADED at the inception of the relationships, sneaky!

1 · Reply

Czar100 May. 15 at 2:02 PM

$CRMD Make no mistake here, as mentioned by previous posters when (not “if”) the KCAPA bill passes through both houses of congress and is signed into law then $CRMD will move exponentially (and perhaps even irrationally) higher on SP. This is all just a matter of time.

0 · Reply

Andy1063 May. 15 at 1:59 PM

$CRMD Wow...smh

3 · Reply

TheOzzman1992 May. 15 at 1:34 PM

$CRMD praying my $9 covered calls get pulled today.

1 · Reply

Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

May 14, 2026, 8:30 AM EDT - 1 day ago

CorMedix Earnings Call Transcript: Q1 2026

2026-05-14T11:53:51.000Z - 1 day ago

CorMedix reports Q1 EPS 43c, consensus 33c

2026-05-14T11:47:54.000Z - 1 day ago

CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M

May 14, 2026, 7:30 AM EDT - 1 day ago

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 5, 2026, 8:30 AM EDT - 10 days ago

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

2026-04-28T19:40:19.000Z - 16 days ago

Citizens healthcare analysts hold an analyst/industry conference call

2026-04-28T11:56:23.000Z - 17 days ago

CorMedix price target raised to $14 from $13 at RBC Capital

2026-04-27T12:05:37.000Z - 18 days ago

CorMedix announces ReSPECT clinical trial met primary endpoint

Apr 27, 2026, 7:30 AM EDT - 18 days ago

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Apr 14, 2026, 3:00 PM EDT - 4 weeks ago

CorMedix Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 7, 2026, 8:30 AM EDT - 5 weeks ago

CorMedix to Participate in Needham Virtual Healthcare Conference

Mar 11, 2026, 9:35 AM EDT - 2 months ago

CorMedix Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 1:00 PM EDT - 2 months ago

CorMedix Transcript: Leerink Global Healthcare Conference 2026

2026-03-06T22:20:58.000Z - 2 months ago

CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M

2026-03-06T17:05:52.000Z - 2 months ago

CorMedix price target lowered to $13 from $15 at Leerink

Mar 5, 2026, 12:58 PM EST - 2 months ago

CorMedix stock drops after earnings: is this dip a buy before key catalyst?

Mar 5, 2026, 8:30 AM EST - 2 months ago

CorMedix Earnings Call Transcript: Q4 2025

2026-03-05T12:36:24.000Z - 2 months ago

CorMedix reports Q4 EPS 16c vs 20c last year

Mar 5, 2026, 7:30 AM EST - 2 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 2, 2026, 8:30 AM EST - 2 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

Feb 12, 2026, 8:30 AM EST - 3 months ago

CorMedix to Participate in Upcoming Investor Conferences

Feb 10, 2026, 1:00 PM EST - 3 months ago

CorMedix Transcript: Investor Day 2026

2026-02-02T13:35:15.000Z - 3 months ago

CorMedix board authorizes share repurchase program of up to $75M

Feb 2, 2026, 8:30 AM EST - 3 months ago

CorMedix Therapeutics Announces Share Repurchase Program

Jan 29, 2026, 8:30 AM EST - 3 months ago

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026

2026-01-23T11:10:42.000Z - 4 months ago

CorMedix price target lowered to $13 from $18 at H.C. Wainwright

2026-01-21T11:35:46.000Z - 4 months ago

CorMedix price target lowered to $13 from $22 at RBC Capital

Jan 12, 2026, 7:30 PM EST - 4 months ago

CorMedix Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 8:30 AM EST - 4 months ago

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 1:37 PM EST - 4 months ago

Why is CorMedix stock crashing today: is it worth buying on the dip?

2026-01-08T17:45:22.000Z - 4 months ago

CorMedix price target lowered to $16 from $20 at Truist

2026-01-08T13:17:12.000Z - 4 months ago

CorMedix sees FY26 revenue $300M-$320M

2026-01-08T13:17:02.000Z - 4 months ago

CorMedix CEO Joseph Todisco signs extended employment contract

Jan 8, 2026, 8:05 AM EST - 4 months ago

CorMedix Therapeutics Announces Leadership and Board Updates

Jan 8, 2026, 8:00 AM EST - 4 months ago

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Dec 18, 2025, 8:00 AM EST - 5 months ago

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

Nov 12, 2025, 4:05 PM EST - 6 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH

Nov 12, 2025, 8:30 AM EST - 6 months ago

CorMedix Earnings Call Transcript: Q3 2025

Nov 12, 2025, 7:30 AM EST - 6 months ago

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Oct 31, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

Oct 23, 2025, 8:30 AM EDT - 7 months ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 22, 2025, 4:05 PM EDT - 7 months ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 20, 2025, 9:42 AM EDT - 7 months ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

Oct 20, 2025, 7:30 AM EDT - 7 months ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Sep 29, 2025, 8:30 AM EDT - 8 months ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 10, 2025, 10:45 AM EDT - 8 months ago

CorMedix Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 8:30 AM EDT - 8 months ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Sep 8, 2025, 8:30 AM EDT - 8 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

Sep 5, 2025, 8:35 AM EDT - 9 months ago

CorMedix Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 7:30 AM EDT - 9 months ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Aug 7, 2025, 10:49 AM EDT - 10 months ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 7:10 AM EDT - 10 months ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:00 AM EDT - 10 months ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 10 months ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jun 27, 2025, 8:00 AM EDT - 11 months ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 11 months ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 11 months ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 3:45 PM EDT - 1 year ago

CorMedix Transcript: Jefferies Global Healthcare Conference 2025

May 30, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 21, 2025, 3:05 PM EDT - 1 year ago

CorMedix Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 8, 2025, 11:00 AM EDT - 1 year ago

CorMedix Transcript: The Citizens JMP Life Sciences Conference 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings Call Transcript: Q1 2025

May 6, 2025, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 8, 2025, 2:15 PM EDT - 1 year ago

CorMedix Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 7:30 AM EDT - 1 year ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 25, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings Call Transcript: Q4 2024

Mar 25, 2025, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ReturnOfEsquire May. 15 at 2:54 PM

$CRMD I'm no legislative expert, but 20 co-sponsors sounds like a lot to me. That's almost 5% of House of Representatives. And it's bipartisan. Hard to believe this would get derailed.

0 · Reply

CRMDepressed May. 15 at 2:52 PM

$CRMD ……wtf man

0 · Reply

golfguy42360 May. 15 at 2:50 PM

$CRMD Dumped another 500 shares today while I'm up .Been loading up on $FNUC been on a tear last couple days.sick of of this incompetent CEO.

0 · Reply

Shibby_Boss May. 15 at 2:42 PM

$CRMD did pur CEO start speaking?

0 · Reply

richmando May. 15 at 2:31 PM

$CRMD who would have thought we were a chip stock.

0 · Reply

richmando May. 15 at 2:27 PM

$CRMD Do we FLIP or what

0 · Reply

richmando May. 15 at 2:23 PM

1 · Reply

Czar100 May. 15 at 2:02 PM

0 · Reply

Andy1063 May. 15 at 1:59 PM

$CRMD Wow...smh

3 · Reply

TheOzzman1992 May. 15 at 1:34 PM

$CRMD praying my $9 covered calls get pulled today.

1 · Reply

focafoca99 May. 15 at 1:15 PM

$CRMD participates in two upcoming investor conferences in New York this May and June. https://www.rapidticker.com/news/crmd-cormedix-therapeutics-to-participate-in-711654

0 · Reply

Andy1063 May. 15 at 1:06 PM

$CRMD

1 · Reply

btdb May. 15 at 12:49 PM

$CRMD modeling eps

0 · Reply

TwongStocks May. 15 at 12:44 PM

$CRMD Deep Track Capital updated their 13G filing https://www.sec.gov/Archives/edgar/data/1410098/000117266126002026/xslSCHEDULE_13G_X02/primary_doc.xml Reporting beneficial ownership of 6,274,076 shares, 7.94%, as of March 31. Beneficial ownership calculated based on 79,050,395 shares outstanding as of Mar 2. In Dec, Deep Track previously reported beneficial ownership of 4,955,487 shares https://www.sec.gov/Archives/edgar/data/1410098/000117266125005229/xslSCHEDULE_13G_X01/primary_doc.xml

1 · Reply

ZacksResearch May. 15 at 12:36 PM

"$CRMD just raised guidance after a Q1 beat 🚀 💉 DefenCath revenue surged to $97.5M on stronger dialysis customer demand 📈 Q1 EPS came in at 43 cents vs. the 35-cent Zacks Consensus Estimate 💰 2026 revenue guidance raised to $325M-$345M as management sees continued utilization momentum The company also boosted adjusted EBITDA guidance and highlighted positive phase III Rezzayo data, adding another potential growth driver to the story. Latest CRMD news here👉 " https://www.zacks.com/stock/quote/CRMD?cid=sm-stocktwits-0-quote_overview-teaser-38100&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_TEASER_38100

0 · Reply

TwongStocks May. 15 at 12:32 PM

$CRMD Two upcoming Investor Conferences. RBC Capital Markets, May 20 at 11am ET: https://kvgo.com/rbc/cormedix-inc-may-2026 Jefferies Global Healthcare Conference, June 3 at 4:20pm ET: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/guest_book?session_id=X5WgzhEQ5pZsM5vPbHaN8q

0 · Reply

Comeasuare May. 15 at 12:27 PM

$CRMD No steak no sizzle.

0 · Reply

flabb May. 15 at 12:14 PM

$DVLT .58 filled Goooooood morning stocktwitters. opportunity everywherre . $CLF 10.68 filled order in 10.65 and lower $PLUG orders in down to 3.35 $FIGS adding anywhere under 12.00 $CRMD adding abywhere under 8..00”

0 · Reply

Noname2022 May. 15 at 11:41 AM

$CRMD USRC - Defencath now standard of care according to this…

0 · Reply

Noname2022 May. 15 at 11:40 AM

$CRMD Fresenius talking about Defencath… https://m.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185?ampMode=1

1 · Reply

Noname2022 May. 15 at 11:38 AM

$CRMD IRC - 90% reductions in BSI (2nd longest customer) *I believe Joe referenced this…

0 · Reply

CaliEmpress May. 15 at 11:31 AM

$CRMD Based on this revenue stream for DefenCath, if Joe were to unload and sell DefenCath in preparation for Rezafungin prophylaxis, what would be a fair price to sell a DefenCath for?

0 · Reply

Market Cap	588.32M
Revenue (ttm)	311.71M
Net Income (ttm)	163.06M
EPS (ttm)	N/A
PE Ratio	4.27
Forward PE	17.07
Profit Margin	52.31%
Debt to Equity Ratio	0.00

Volume	4,320,600
Avg Vol	1,322,778
Day's Range	N/A - N/A
Shares Out	78.44M
Stochastic %K	33%
Beta	1.46
Analysts	Strong Sell
Price Target	$15.00